SetPoint Medical Corp

VALENCIA, CA · Founded 2006 · Medtech · Private

Wireless implantable vagus nerve stimulation device for neuroimmune modulation

Claim this profile

Follows are private to you and power your alerts

Updated · setpointmedical.com

Sector
Medtech
Headquarters
VALENCIA, CA
Founded
2006
Latest Form D
$115M, Apr 2025
Total capital
$294M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$294M
9 Form D · last Apr 2025
19 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

20092013201720212025FEDERAL ↑EQUITY ↓Cumulative $294M6th Form D$15.7M
20092013201720212025FEDERAL ↑EQUITY ↓Cumulative $294M

Latest events

  • Private capital raisedForm D · SEC · 9th filing$115M
  • Private capital raisedForm D · SEC · 8th filing$55M
  • Private capital raisedForm D · SEC · 7th filing$52.4M
  • Private capital raisedForm D · SEC · 6th filing$15.7M
  • Private capital raisedForm D · SEC · 5th filing$15.1M
  • Private capital raisedForm D · SEC · 4th filing$30.6M
  • Private capital raisedForm D · SEC · 3rd filing$1.5M
  • Private capital raisedForm D · SEC · 2nd filing$5M
  • Private capital raisedForm D · SEC · 1st filing$4M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Alan J. WillDirectorNamed in SEC Form D filings
  • Allan WillDirectorNamed in SEC Form D filings
  • Andrew FirlikDirectorNamed in SEC Form D filings
  • Anthony ArnoldExecutive Officer, DirectorNamed in SEC Form D filings
  • Bill GearyDirectorNamed in SEC Form D filings
  • Blake WuDirectorNamed in SEC Form D filings
Show all 28 people
  • Christopher KasterDirectorNamed in SEC Form D filings
  • Colin J. MorrisonDirectorNamed in SEC Form D filings
  • David J ChernoffExecutive OfficerNamed in SEC Form D filings
  • David NeustaedterDirectorNamed in SEC Form D filings
  • Hank PlainDirectorNamed in SEC Form D filings
  • H. Shaw WarrenDirectorNamed in SEC Form D filings
  • H. SHAW WARRENDirectorNamed in SEC Form D filings
  • James BroderickDirectorNamed in SEC Form D filings
  • JAMES F. BUCKExecutive Officer, DirectorNamed in SEC Form D filings
  • Joe J. BillerDirectorNamed in SEC Form D filings
  • JOHN HARRISDirectorNamed in SEC Form D filings
  • Josh J MakowerDirectorNamed in SEC Form D filings
  • Juan-Pablo MasDirectorNamed in SEC Form D filings
  • KERRY BLACKExecutive OfficerNamed in SEC Form D filings
  • Kevin J ReillyDirectorNamed in SEC Form D filings
  • Kevin J. TraceyExecutive Officer, DirectorNamed in SEC Form D filings
  • Murthy SimhambhatlaExecutive Officer, DirectorNamed in SEC Form D filings
  • Rohan J SethExecutive OfficerNamed in SEC Form D filings
  • Steven J. WinickDirectorNamed in SEC Form D filings
  • Tyler J BinneyDirectorNamed in SEC Form D filings
  • William J. DaiDirectorNamed in SEC Form D filings
  • Zack J ScottDirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • NURO INCSimilar federal contract value in Medtech · null in contracts
  • INTERPACE BIOSCIENCES, INC.Similar federal contract value in Medtech · null in contracts
  • Respicardia, Inc.Similar federal contract value in Medtech · null in contracts
  • HOLOGIC INCSimilar federal contract value in Medtech · null in contracts
  • VAIL SCIENTIFIC, INC.Similar federal contract value in Medtech · null in contracts
  • Xact Medical, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .